RU2006124746A - Имитаторы супероксиддисмутазы для лечения повреждения зрительного нерва и сетчатки - Google Patents

Имитаторы супероксиддисмутазы для лечения повреждения зрительного нерва и сетчатки Download PDF

Info

Publication number
RU2006124746A
RU2006124746A RU2006124746/14A RU2006124746A RU2006124746A RU 2006124746 A RU2006124746 A RU 2006124746A RU 2006124746/14 A RU2006124746/14 A RU 2006124746/14A RU 2006124746 A RU2006124746 A RU 2006124746A RU 2006124746 A RU2006124746 A RU 2006124746A
Authority
RU
Russia
Prior art keywords
group
alkyl
cycloalkenyl
cycloalkyl
alkynyl
Prior art date
Application number
RU2006124746/14A
Other languages
English (en)
Russian (ru)
Inventor
Питер Г. КЛИМКО (US)
Питер Г. КЛИМКО
Original Assignee
Алькон, Инк. (Ch)
Алькон, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Алькон, Инк. (Ch), Алькон, Инк. filed Critical Алькон, Инк. (Ch)
Publication of RU2006124746A publication Critical patent/RU2006124746A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
RU2006124746/14A 2003-12-11 2004-11-30 Имитаторы супероксиддисмутазы для лечения повреждения зрительного нерва и сетчатки RU2006124746A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52883003P 2003-12-11 2003-12-11
US60/528,830 2003-12-11

Publications (1)

Publication Number Publication Date
RU2006124746A true RU2006124746A (ru) 2008-01-20

Family

ID=34710102

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006124746/14A RU2006124746A (ru) 2003-12-11 2004-11-30 Имитаторы супероксиддисмутазы для лечения повреждения зрительного нерва и сетчатки

Country Status (12)

Country Link
US (3) US20070060557A1 (cg-RX-API-DMAC7.html)
EP (1) EP1691815A4 (cg-RX-API-DMAC7.html)
JP (1) JP2007513948A (cg-RX-API-DMAC7.html)
KR (1) KR20060101501A (cg-RX-API-DMAC7.html)
CN (1) CN1889961A (cg-RX-API-DMAC7.html)
AU (1) AU2004305531B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0417549A (cg-RX-API-DMAC7.html)
CA (1) CA2545762A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA06006187A (cg-RX-API-DMAC7.html)
RU (1) RU2006124746A (cg-RX-API-DMAC7.html)
WO (1) WO2005060974A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200603347B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1889961A (zh) * 2003-12-11 2007-01-03 爱尔康公司 用于治疗视神经和视网膜损伤的超氧化物歧化酶拟似物
KR100724586B1 (ko) 2005-12-09 2007-06-04 세종대학교산학협력단 수퍼옥사이드 디스뮤타아제 활성을 갖는 고리화합물
US8598150B1 (en) 2008-04-02 2013-12-03 Jonathan R. Brestoff Composition and method for affecting obesity and related conditions
US8987245B2 (en) 2008-04-02 2015-03-24 Jonathan R. Brestoff Parker Composition and method for affecting obesity and related conditions
US20190388548A1 (en) * 2018-06-26 2019-12-26 Tzu Chi University Method for providing ocular neuroprotection or for preventing, treating or alleviating the effects of, an ocular disease associated with retinal ganglion cell death

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4550022A (en) * 1981-10-05 1985-10-29 Alcon Laboratories, Inc. Tissue irrigating solution
DE3773926D1 (de) * 1987-07-22 1991-11-21 Farvalsa Ag Feuchtigkeitsstabile feste valproinsaeure-zubereitung und verfahren zu ihrer herstellung.
US6127356A (en) * 1993-10-15 2000-10-03 Duke University Oxidant scavengers
US5994339A (en) * 1993-10-15 1999-11-30 University Of Alabama At Birmingham Research Foundation Oxidant scavengers
SE9402816D0 (sv) * 1994-08-24 1994-08-24 Pharmacia Ab Method and meams for drug administration
US6180620B1 (en) * 1997-06-20 2001-01-30 G.D. Searle & Co. Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals
US6214817B1 (en) * 1997-06-20 2001-04-10 Monsanto Company Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
AU5251999A (en) 1998-08-04 2000-02-28 Wisconsin Alumni Research Foundation Method of reducing retinal ganglion cell degeneration
GB9817845D0 (en) * 1998-08-17 1998-10-14 Glaxo Group Ltd Chemical compounds
WO2000023568A2 (en) 1998-10-06 2000-04-27 Albert Einstein College Of Medicine Of Yeshiva University Methods and compositions for decreasing mitochondrial overproduction of reactive oxygen species in cells
ES2240101T3 (es) 1999-05-27 2005-10-16 Monsanto Company Biomateriales modificados con mimeticos de superoxido dismutasa.
DE60231246D1 (de) * 2001-12-14 2009-04-02 Alcon Inc Superoxiddismutas-mimetika zur behandlung von augenerkrankungen
CN1889961A (zh) * 2003-12-11 2007-01-03 爱尔康公司 用于治疗视神经和视网膜损伤的超氧化物歧化酶拟似物

Also Published As

Publication number Publication date
AU2004305531A1 (en) 2005-07-07
WO2005060974A1 (en) 2005-07-07
AU2004305531B2 (en) 2009-11-26
EP1691815A4 (en) 2010-03-31
US20070060557A1 (en) 2007-03-15
US20110105453A1 (en) 2011-05-05
US20050130951A1 (en) 2005-06-16
CN1889961A (zh) 2007-01-03
ZA200603347B (en) 2009-02-25
MXPA06006187A (es) 2006-08-25
CA2545762A1 (en) 2005-07-07
EP1691815A1 (en) 2006-08-23
KR20060101501A (ko) 2006-09-25
JP2007513948A (ja) 2007-05-31
BRPI0417549A (pt) 2007-03-27

Similar Documents

Publication Publication Date Title
CO4810291A1 (es) Composiciones fungicidas y metodos y compuestos y metodos para la preparacion de estos
CA2405521A1 (en) Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties
EA200600990A1 (ru) Производные бензосульфониламинопиридин-2-ила и родственные соединения в качестве ингибиторов 11-бета-гидроксистероид-дегидрогеназы 1 типа (11-бета-hsd-1) для лечения диабета и ожирения
AR087046A2 (es) Compuestos derivados de 4-oxoquinolina
BR0114044A (pt) Prendedor de esclerótica e procedimentos para utilizar o mesmo
KR900015729A (ko) 흥분성 아미노산 길항제
KR870007137A (ko) 치환 피리딘술폰아미드 화합물, 이들을 함유하는 제초 조성물 및 이들 화합물의 제조 방법.
SK6532003A3 (en) Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as a medicament, and pharmaceutical preparations containing these compounds
KR970702255A (ko) 벤즈아미드 화합물 및 그의 약제학적 용도(benzamide compounds and pharmaceutical use thereof)
CA2443918A1 (en) Visual function disorder improving agents containing rho kinase inhibitors
TW200745029A (en) Sulfonamide derivatives exhibiting PGD2 receptor antagonism
DE10061876A1 (de) Arylierte Furan- und Thiophencarbonsäureamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DK1031563T3 (da) Sulfonylderivater
RU2008130111A (ru) (индазол-5-ил)пиразины и (1,3-дигидроиндол-2-он)пиразины для лечения опосредованнызх rно-киназой заболеваний и состояний
NO20065494L (no) Fuserte kinolinderivater og anvendelse derav
TW200503692A (en) Therapeutic agents
DK1063228T5 (da) Cycloalkenderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf
KR940005274A (ko) 쇼그렌(Sjoegren)증후군 치료제
AR035196A1 (es) Derivados de guanidina o biguanidina y el uso de los mismos para la fabricacion de medicamentos antivirales y antimicrobianos
MX2024015383A (es) Compuesto de amina ciclica de azacicloalquilcarbonilo
RU2003105891A (ru) Производные индола, способ их получения и их применение, лекарственное средство и способ лечения опухолевого заболевания млекопитающего
HU9401161D0 (en) Oxazolidone derivatives, process for producing them and pharmaceutical compositions containing them
MY139586A (en) Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives for reducing ichaemic damage
CA2470721A1 (en) Superoxide dismutase mimics for the treatment of ocular disorders and diseases
MX2025001111A (es) Nuevas sulfonamidas y su uso como agentes neuroprotectores y/o neurorrestauradores

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20090821